PIN1 and cancer: Since increasing evidence has shown that Pin1 is a potential target for cancer therapy, several groups have developed potent antagonists, including chemical compounds, natural products, and peptide drugs, to block Pin1 (Urusova et al., 2011; Moore and Potter, 2013).